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Tbjective: Single-lung transplantation for chronic obstructive pulmonary disease can
ause unique postoperative problems that might require independent lung ventilation.
e evaluated preoperative and immediate postoperative factors to predict the need for
ndependent lung ventilation.
ethods: We retrospectively studied 170 patients who received a single-lung transplant
ver a 15-year period, 20 (12%) of whom required independent lung ventilation.
esults: Patients requiring independent lung ventilation were similar in age, sex,
schemic time, and donor characteristics to those who required conventional venti-
ation. Patients receiving independent lung ventilation had a greater degree of
reoperative airflow limitation, more hyperinflation, lower postoperative PaO2/
raction of inspired oxygen ratios, more radiologic mediastinal shift, and more
ransplant lung infiltrate on the postoperative chest radiograph. Multivariate logistic
egression analysis showed that independent lung ventilation was associated with
ncreasing levels of recipient hyperinflation (percentage total lung capacity com-
ared with predicted value; odds ratio, 1.04; 95% confidence interval, 1.01-1.07;
 .032) and reduced early postoperative PaO2/fraction of inspired oxygen ratio
odds ratio, 0.97; 95% confidence interval, 0.95-0.99; P  .005). Length of venti-
ation and intensive care unit stay and mortality were higher in the independent lung
entilation group. Among patients who survived to hospital discharge, there were no
ifferences in long-term mortality between the 2 groups.
onclusions: The need for independent lung ventilation in patients undergoing
ingle-lung transplantation for obstructive lung disease is predicted by the combi-
ation of increased hyperinflation measured on recipients’ preoperative lung func-
ion tests and a low PaO2/fraction of inspired oxygen ratio, indicating graft dysfunc-
ion in the immediate postoperative period.
 
n t i l 2 successful cases of single-lung transplantation (SLT) for end-stage
emphysema were reported by Mal and colleagues1 in 1989, SLT was consid-
ered to be contraindicated in patients with chronic obstructive pulmonary
isease (COPD). Initial concerns were that hyperexpansion of the native lung would
ompress the graft and that the higher vascular resistance of the native lung would divert
xcessive blood flow to the transplant lung, with the combination leading to unaccept-
he Journal of Thoracic and Cardiovascular Surgery ● Volume 133, Number 4 1071
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1
TXble ventilation-perfusion mismatch. Experimental studies and
wo successful SLTs for emphysema did much to alleviate
hese concerns and supported the feasibility of the procedure.2
hese authors showed that significant ventilation-perfusion
ismatch and arterial hypoxemia did not occur unless rejec-
ion, infection, or reperfusion injury developed in the transplant
ung. Since then, end-stage emphysema has become the most
ommon indication for SLT. In recent years, however, there
as been an increasing tendency to perform double-lung trans-
lantations for these patients because of a long-term survival
dvantage.3
After transplantation, the new allograft is predisposed to
arly injury from a variety of sources. These include primary
raft dysfunction, injury caused by lung handling, fluid loading
n a lung with increased permeability and absent lymphatic
rainage, early infection, and, in occasional patients, impaired
enous drainage. When early lung allograft injury does occur,
t can lead to atelectasis, hypoxia, hypercapnia, and reduced
ompliance in the transplant lung. The latter increases the
roportion of ventilation to the native lung, thereby increas-
ng its dynamic hyperinflation, and can lead to increased
ntrathoracic pressure, circulatory compromise, and increas-
ng mediastinal shift, with further atelectasis and shunt in
he transplant lung. Attempts to alleviate hypoxia, hyper-
apnia, and transplant lung atelectasis by increasing ven-
ilation or positive end-expiratory pressure (PEEP) often
ncrease dynamic hyperinflation in the native lung and
orsen atelectasis and gas exchange in the transplant
ung.4 This remains a serious problem, especially in the
arly postoperative period. Because the ventilation and
EEP requirements of the transplant lung aggravate dy-
amic hyperinflation in the native (COPD) lung, inde-
endent-lung ventilation (ILV) has been proposed as a
uccessful treatment of early postoperative dynamic hy-
erinflation and graft failure.5,6
The principal aim of our study was to identify preoper-
tive and early postoperative predictors for the need for ILV
n patients who received ILV in clinical management. We
ypothesized that a number of factors might combine to
etermine the requirement for ILV: pre-existing dynamic
ecipient hyperinflation, postoperative hyperinflation of the
Abbreviations and Acronyms
COPD chronic obstructive pulmonary disease
FEV1  forced expiratory volume in 1 second
ICU  intensive care unit
ILV  independent lung ventilation
PEEP  positive end-expiratory pressure
SLT  single-lung transplantation
TLC  total lung capacityative lung, size mismatch between the native and trans- c
072 The Journal of Thoracic and Cardiovascular Surgery ● Aprlanted lungs, mediastinal shift caused by hyperinflation of
he native lung, and injury to the transplanted lung. Addi-
ional aims were to study the early and long-term outcomes
duration of ventilation, length of stay in the intensive care
nit [ICU], hospital mortality, and survival after leaving the
ospital) of patients requiring ILV compared with those of
atients not receiving ILV.
aterials and Methods
retrospective chart, medical record, and database review of
ll SLTs performed from October 1990 (when the service
egan) until October 2005 was conducted. Patients who re-
eived an SLT for obstructive lung diseases were identified for
nalysis. Variables were grouped into those that were available
reoperatively and those that could be assessed in the immedi-
te postoperative period.
reoperative Variables
ecipients’ age, sex, height, weight, lung function test results, and
hest radiographic measurements were recorded. Donor factors
ncluded were age, sex, height, PaO2 (taken on a fraction of
nspired oxygen [FIO2] of 100% and a 5 cm H2O PEEP), and
stimated total lung capacity (TLC).7 Total graft ischemic time for
he organ was also recorded.
ostoperative Variables
stimates of lung size and mediastinal shift were taken by using
he first postoperative chest radiograph and compared with the
ost recent preoperative radiograph. The severity of transplant
ung infiltrate was graded from 0 (absence of infiltrate) to 4 (dense
lveolar consolidation of the entire lung field).8 Gas exchange was
ssessed by recording the lowest PaO2/FIO2 ratio in the first 24
ours or before instituting ILV (whichever came first).
We analyzed variables as predictors for the need for ILV by
omparing preoperative and early postoperative findings in the
LV and non-ILV groups during the first 24 postoperative hours.
utcome parameters were compared between the ILV and non-
LV groups. Outcomes assessed were incidence of ILV, duration
f mechanical ventilation, duration of stay in the ICU, ICU mor-
ality, hospital mortality, and long-term survival.
eneral Method for SLT
plit-lung function studies were performed on all patients (nuclear
uantitative perfusion scans). The worst functional side was al-
ays selected for transplantation. There were insufficient retro-
pective data to include this in our analysis. General methods for
ecipient selection, donor selection, pulmonary allograft procure-
ent, surgical technique for SLT, and postoperative management
ave been described in detail previously.4,9-11 However, principles
ncluded immunosuppressive and antiviral therapy (described pre-
iously),12 maintenance of low central venous pressure, minimal
EEP, active airway clearance, maximal bronchodilator therapy,
nd nitric oxide, where appropriate.
ndications for ILV
here was no protocol for the initiation of ILV. Treating
linicians instigated ILV on the basis of one or a combina-
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TXion of the following: (1) serious hemodynamic compromise
ttributed to excessive dynamic hyperinflation and (2) serious
as exchange compromise attributed to excessive dynamic
yperinflation.
Transplant lung infiltrate on chest radiography was usually
resent but was not by itself an indication for ILV. Asymptomatic
yperinflation was not considered an indication for ILV.
echnical Aspects of ILV
atients who required ILV were intubated with a double-lumen
ndotracheal tube (Bronchocath; Mallinckrodt, Athlone, Ireland;
ize range, 35F-41F). The side of the bronchial lumen was posi-
ioned bronchoscopically to lie in the main bronchus of the native
ung to avoid injury to the bronchial anastomosis. In all patients,
synchronous ILV was used. The native lung was ventilated with
ow tidal volumes (3-6 mL/kg), a low ventilator rate (3-6 breaths/
in), and 0 PEEP or not ventilated at all by using continuous
ositive airway pressure (5 cm H2O). The transplanted lung was
entilated with higher ventilator rates (10-26 breaths/min) and
ariable tidal volumes (3.5-10 mL/kg). PEEP (5-15 cm H2O) was
djusted to achieve a maximal improvement in gas exchange and
ompliance.
tatistical Analysis
ll data are expressed as means  standard deviation. Data were
nalyzed by using the Student t test and Wilcoxon and 2 tests as
ppropriate. A stepwise multivariate logistic regression model was
sed to correct for the effect of multiple variables and their
nteractions on requiring ILV in the early postoperative period.
ariables that were associated with the requirement for ILV at a P
alue of less than .1 in the univariate analysis were entered into the
ultivariate model. The initial model was constructed by using
reoperative variables. Postoperative variables were selected af-
erward and then incorporated into the final model. Software used
as SAS version 9.1.3 (Enterprise Guide) for Windows (SAS
nstitute, Inc, Cary, NC).
esults
f 211 SLTs performed between October 1990 (when the
ervice began) and October 2005, 170 patients received
n SLT for obstructive lung diseases (133 for emphysema
aused by smoking, 23 for emphysema caused by 1-
ntitrypsin deficiency, 8 for obliterative bronchiolitis, 4
or lymphangioleiomyomatosis, 1 for agammaglobuline-
ia, and 1 for asthma). These 170 patients formed the basis
f our analysis. ILV was used in 12% (20/170) of SLTs for
bstructive lung disease. One of these 20 patients had oblit-
rative bronchiolitis; the remainder had emphysema caused
y smoking. Other than one case, in which the patient was
eturned to the ICU from the operating theater with a
ouble-lumen endotracheal tube in situ, ILV was instigated
y the treating intensivist. ILV was initiated within the first
4 hours in 19 patients. One patient had a pneumothorax in
he native lung on the fourth postoperative day, and this
atient’s condition subsequently deteriorated, requiring
LV. There was one instance of ILV use in a patient with r
The Journal of Thoracicestrictive lung disease caused by pulmonary fibrosis (be-
ore institution of extracorporeal membrane oxygenation),
nd this patient was not included in this study.
Demographic data for all patients receiving an SLT for
OPD are shown in Table 1. The mean age for the whole
ohort was typical for this patient group, and there was a
emale preponderance.
Table 2 shows the lung function and chest radiographic
ssessments available in the preoperative period. All recip-
ents had severe airflow limitation. Those who subsequently
equired ILV had lower forced expiratory volume in 1
econd (FEV1) to forced vital capacity ratios expressed as a
ercentage of predicted value. Patients undergoing ILV had
reater degrees of functional hyperinflation, higher TLC
xpressed as a percentage of predicted value and functional
esidual capacity expressed as a percentage of predicted
alue, than those who required only conventional ventila-
ion postoperatively. Of those patients who had TLCs
reater than 150% of predicted value, 26.5% (9/34) required
LV compared with only 6.6% (8/121) of those with TLCs
ess than this value (P .003). Indeed, of the 9 patients who
ad TLCs greater than 175% of predicted value, 4 (ie, 44%)
equired ILV. There were no significant differences between
he radiologic assessments of lung size (in donors and
ecipients) between both groups.
Table 3 shows data from the immediate postoperative
eriod. The patients who needed ILV had greater degrees of
ulmonary infiltrate (P  .001), worse gas exchange (P 
001), and more mediastinal shift (P  .018). A PaO2/FIO2
ABLE 1. Comparison of baseline preoperative demo-
raphic data for the ILV and conventional ventilation
roups
ILV (n  20)
Conventional
ventilation
(n  150)
P
value
ecipient variables
Left lung transplants 14/20 (70%) 68/150 (45%) .037
Age (y) 54.9 4.9 53.9 7.5 .447
Sex (female/male) 12/20 (60%) 81/150 (54%) .613
Height (cm) 162 11 164  9 .484
Weight (kg) 51.4 13.1 60.9 12.6 .216
Lung volume reduction
surgery before
transplantation
1/20 (5%) 4/150 (2.7%) .469
onor variables
Donor age (y) 35.2 13.5 34.6 13.3 .848
Donor PaO2 (mm Hg) 480 107 468 77 .538
Donor height (cm) 175 10 174  8 .500
schemic time (min) 352 149 338 127 .639
ll values are presented as means  standard deviation. ILV, Independent
ung ventilation.atio of less than 100 was observed in 61.1% (11/18) of
and Cardiovascular Surgery ● Volume 133, Number 4 1073
p
p
m
b
n
(
c
g
p
c
T
p
t
p
T
s
a
.
d
2
2
o
r
a
a
o
s
p
s
s
w
t
g
T
P
P
E
F g cap
T
P
P
F
Cardiothoracic Transplantation Pilcher et al
1
TXatients in the ILV group as opposed to only 11% (15/136)
atients requiring conventional ventilation. Although the
ean amount of radiologic mediastinal shift was different
etween the 2 groups, the presence of significant mediasti-
al shift (2.5 cm) was a relatively poor discriminator
45% of patients in the ILV group as opposed to 32% in the
onventional ventilation group). Two patients in the ILV
roup had only 1 cm or less mediastinal shift on radiogra-
hy. Both of these patients had significant cardiovascular
ompromise, with low cardiac output and hypotension.
heir PaO2/FIO2 ratios were 97 and 170, respectively. Five
atients in the conventional ventilation group had medias-
inal shift greater than or equal to 4 cm.
ILV was required more commonly after left lung trans-
lantation (left: 17% [14/82] vs right: 7% [6/88], P .037).
here were nonsignificant trends toward more mediastinal
hift (1.8 1.4 cm vs 1.5 1.2 cm, respectively; P .158)
nd higher hospital mortality (left: 10/72 vs right: 5/83, P
ABLE 2. Comparison of preoperative lung function and ra
Independen
(n
reoperative lung function
FEV1/FVC 27%
FEV1/FVC % predicted 33%
FEV1 % predicted 23%
FRC % predicted 241%
TLC % predicted 149%
Ratio of recipient measured TLC to
donor estimated TLC
1.4
reoperative radiographic assessment
Size mismatch between donor and recipient lungs
Percentage by which recipient’s lung
to remain in situ  donor lung
20.9%
Percentage by which recipient’s lung
to be explanted  donor lung
20.6%
quations for estimating normal lung function value were taken from the
VC, forced vital capacity; FRC, functional residual capacity; TLC, total lun
ABLE 3. Comparison of postoperative variables
Independ
ostoperative gas exchange
PaO2/FIO2 ratio (mm Hg)
ostoperative radiographic assessment
Lung infiltrate score
Mediastinal shift (cm)* 
Percentage by which transplanted lung in
recipient was bigger than when in donor
10
Percentage by which recipient’s native
lung was bigger than transplanted lung
7IO2, Fraction of inspired oxygen. * value  shift toward transplanted lung.
074 The Journal of Thoracic and Cardiovascular Surgery ● Apr178) in left compared with right lung transplants. However,
uration of ventilation (left: 8.0 hours [interquartile range,
.5-23.5 hours] vs right: 7.0 hours [interquartile range,
.3-18.8 hours], P  .671) was similar.
The multivariate analysis (Table 4) demonstrated that the
nly 2 factors that were significantly associated with the
equirement for ILV were TLC percent predicted (P .032)
nd the postoperative PaO2/FIO2 ratio (P  .005). There was
nonsignificant trend toward a relationship with the degree
f the pulmonary infiltrate (P  .06).
Outcomes of the patients are shown in Table 5. Not
urprisingly, the patients who needed ILV required more
rolonged duration of ventilation (P .001) and had longer
tays in the ICU (P  .005). During the first half of the
tudy period (1990-1998), 6 of 11 patients died compared
ith 2 deaths from 9 patients during the later years. Al-
hough not statistically significant (P  .19), this was sug-
estive of a learning-curve effect. Indeed, of the first 4
ogic variables
ventilation
0)
Conventional ventilation
(n  150) P value
% 30% 13% .094
% 40% 18% .021
% 24% 10% .261
9% 189% 66% .006
3% 128% 31% .027
.33 1.48 0.24 .609
0.5% 13.6% 15.3% .224
0.5% 13.3% 15.4% .222
by Quanjer and coworkers.7 FEV1, Forced expiratory volume in 1 second;
acity.
ng ventilation
20)
Conventional ventilation
(n  150) P value
42 221 120 .001
1.2 1.2  0.9 .001
1.4 1.5  1.2 .018
7.6% 6.9% 19.2% .690
6.6% 4.7% 9.5% .442diol
t lung
 2
 7
 9
 6
 7
 3
2 0
 1
 1
studyent lu
(n 
99 
2.8
2.4 
.8%
.4%il 2007
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TXatients in whom ILV was attempted, 3 died. The higher
ortality at 1 year in the ILV group (P .001) is accounted
or by the early deaths. Among those who died after hospital
ischarge, the incidence of bronchiolitis obliterans syn-
rome did not differ between the 2 groups (4/7 vs 39/96,
 .447). The Kaplan–Meier curve for the patients who
urvived to hospital discharge is shown in Figure 1. There
as no significant difference in long-term outcomes of
urvivors (P  .352).
iscussion
ur study has shown that increasing hyperinflation (TLC
ercent predicted) in the recipient and subsequent graft
ysfunction (PaO2/FIO2 ratio) in the early postoperative pe-
iod combine and lead to the requirement for ILV.
The reported frequency of use of ILV in SLT series for
bstructive airways disease also varies widely, from 0%13-17
o 43%,18 with an overall frequency of ILV use of 9%.6,13-21
his compares with 12% in our study. In part, this variabil-
ty between series relates to the threshold for using ILV and
o the availability and frequency of use of techniques such
s extracorporeal membrane oxygenation.
A number of other studies have investigated risk factors
or ILV, such as severity of airflow obstruction in the native
ung, the size of the transplanted lung, and the side of the
ransplantation. Severity of airflow obstruction will directly
ABLE 5. Outcomes: Comparison of ILV with conventional
entilation group
ILV (n  20)
Conventional
ventilation (n  150) P value
V duration (h)* 148 (81-162) 7 (0.5-20) .001
CU duration (d)* 6.0 (3.5-7.0) 1.0 (0.25-1.0) .005
CU mortality† 6/20 (30%) 2/150 (1.3%) .001
ospital mortality 8/20 (40%) 7/150 (4.7%) .001
-y mortality 10/20 (50%) 19/148 (12.8%) .001
LV, Independent lung ventilation; MV, mechanical ventilation; ICU, inten-
ive care unit. *Median (interquartile range). †Initial admission to intensive
ABLE 4. Multivariate logistic regression analysis for
ariables associated with a requirement for ILV
Odds ratio
95% Confidence
interval P value
reoperative assessment
TLC % predicted 1.04 1.01-1.07 .032
ostoperative assessment
PaO2/FIO2 ratio 0.97 0.95-0.99 .005
Lung infiltrate score 2 1-4 .060
LV, Independent lung ventilation; TLC, total lung capacity; FIO2, fraction of
nspired oxygen.are unit only.
The Journal of Thoracicffect the degree of dynamic hyperinflation.22 Yonan and
olleagues6 found that patients who had native lung hyper-
nflation had higher pulmonary artery pressures, higher pul-
onary artery to wedge pressure gradients, higher residual
olumes, and lower FEV1 values than patients who did not
ave symptomatic postoperative hyperinflation. Pulmonary
ypertension and a high transpulmonary gradient were not
tudied in our patients. Although we found the degree of
reoperative airflow limitation (FEV1/forced vital capacity
ercent predicted) was worse in the ILV group, this was not
significant factor after multivariate adjustment. Because
ur population size is relatively small, it was unlikely that
e would detect many significant factors in multivariate
nalysis.
The size of the donor lung and its relationship to esti-
ated recipient lung volume has been identified by several
uthors5,17,21 as an important factor. We could not demon-
trate any such relationship using radiologic, measured, or
stimated measures of lung function.
Several reports have suggested a higher incidence of
ative lung hyperinflation with left SLTs. Weill and asso-
iates20 found radiographic hyperinflation in 37% of left
LTs and 25% of right SLTs, with no difference in the
ncidence of symptomatic hyperinflation. Angles and col-
eagues18 did not report radiographic hyperinflation but
ound symptomatic hyperinflation in 83% of left SLTs and
0% of right SLTs. In our study there was no significant
ifference in postoperative native lung hyperinflation (as
videnced by mediastinal shift) between left and right SLTs
1.8  1.4 cm vs 1.5  1.2 cm, respectively; P  .158), but
LV was required more than twice as often with left SLTs.
owever, we have previously reported23 higher long-term
igure 1. Kaplan–Meier survival curve for hospital survivors after
ndependent lung ventilation and after conventional ventilation.
ilcoxon test for difference between survival curves, P  .352.
, Censored values.
and Cardiovascular Surgery ● Volume 133, Number 4 1075
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1
TXortality (primarily because of airway complications) with
eft lung transplants compared with that seen with right lung
ransplants.
A reduced PaO2/FIO2 ratio (odds ratio, 0.97; 95% confi-
ence interval, 0.95-0.99, P  .005) in the immediate post-
perative period was associated with the requirement for
LV. This is not surprising because impaired gas ex-
hange is likely to have been an important factor in
etermining the intensivist’s decision to initiate ILV. A
educed PaO2/FIO2 ratio is the basis of the definition for
rimary graft dysfunction24 and is associated with worse
arly outcomes after lung transplantation.25,26 It is pos-
ible that attempts to improve graft function by providing
reater minute ventilation, PEEP, or a longer inspiratory
ime might worsen dynamic hyperinflation in the native
ung, resulting in hemodynamic deterioration. Fluid ad-
inistration as a treatment for hypotension and low car-
iac output might further jeopardize graft function by
ncreasing edema in the transplanted lung.
Other reported treatment options for severe dynamic
yperinflation in association with early graft failure in-
lude the use of a bronchial blocker,21 contralateral lo-
ectomy or pneumonectomy,27,28 lung volume reduction
urgery of the native lung,29 retransplantation,21 and ex-
racorporeal membrane oxygenation30 (as was required
y one of our patients). It is noteworthy that the reported
ases of lung volume reduction surgery and contralateral
obectomy or pneumonectomy have not been performed
n the setting of early graft injury as an immediate post-
perative complication.
The patients who required ILV had an initial hospital
ortality of 40%, although it is likely that the mortality
ithin this group would have been much higher without this
ntervention. Two case series in which data on all patients
ndergoing SLT and ILV survival were recorded6,19 have
eported mortality rates of 25% and 46%, respectively,
hich is significantly worse than for patients with SLT who
equired only conventional ventilation. However, the study
y Weill and associates,20 which described a mortality of
%, had only 2 patients who required ILV. However, it is
mportant to note that among those who survive to leave the
ospital, satisfactory long-term outcomes can be achieved,
s shown in Figure 1. We know of no other reports on the
ong-term survival of patients who have required ILV.
Potential limitations of our study are that it is a single-
enter, retrospective, nonrandomized analysis of relatively
mall numbers of patients. Generalizing our findings to
ther centers should be done with caution. However, this is
he largest case series of which we are aware. It is possible
hat patient selection for ILV could have been biased by a
esire to optimize results. At our center, there has been a
rend away from SLT for COPD in recent years (15 SLTs
etween 2003 and 2005 compared with 45 in the preceding
076 The Journal of Thoracic and Cardiovascular Surgery ● Apryears). This has been driven by a perceived late survival
dvantage,3 with bilateral transplantation rather than con-
cious selection of patients at risk of needing ILV because
f significant preoperative hyperinflation. We could not
nclude cardiovascular parameters in our study, mainly be-
ause there were insufficient data for most patients. The
resence of hypotension caused by native lung hyperinfla-
ion (with or without a low PaO2/FIO2 ratio) has been con-
idered an absolute indication for initiating ILV at our
ospital. Our aim was to investigate other parameters that
he clinician might use to assess the risk of requiring ILV.
he presence of preoperative hyperinflation with TLC per-
ent predicted of greater than 150% should alert those
electing patients for SLT of a significant risk of requiring
LV in the postoperative period. The additional finding of a
educed PaO2/FIO2 ratio (100) in the immediate postoper-
tive period should prompt early consideration of ILV.
onclusions
LV after SLT is associated with increased duration of
entilation, increased duration of stay in the ICU, and
ncreased mortality. The need for ILV in these patients is
redicted by the combination of increased hyperinflation
increased TLC percent predicted) measured on recipients’
reoperative lung function tests and a low PaO2/FIO2 ratio,
ndicating graft dysfunction in the immediate postoperative
eriod. Long-term outcomes among recipients who require
LV and survive to leave the hospital are comparable with
hose of the group as a whole.
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